Ajay Sheshadri, MD, discusses the advantages of attending CHEST 2023 in person and how these benefits can inspire positive change even after the conference ends.
Seeing colleagues in person at the CHEST Annual Meeting 2023 is a valued opportunity after the COVID-19 pandemic and provides advantages for all areas of medicine even after the conference ends, explains Ajay Sheshadri, MD, associate professor of pulmonary medicine at the University of Texas MD Anderson Cancer Center.
Transcript
Why is it beneficial for chest medicine professionals to meet in person at CHEST 2023?
I think we probably took for granted how great it is to see our colleagues in person before the pandemic. During the pandemic, most of our conferences were virtual, and the engagement with the virtual conference is a lot more difficult. You're not there in person seeing the speakers, you're not able to interact with the speakers, other than through a chat box or perhaps a very closely moderated Q&A, and it doesn't quite feel like you're in a research retreat environment.
So, being around people of like-minded interests really just stimulates your own desire to advance the field forward, and I think gives you a lot of energy to be able to motivate yourself when you come back from the conference. Usually, after the conference, there's a little bit of a buzz as you synthesize all the things that you saw and discussed at the conference. To me, that's been incredibly beneficial. Usually after the meetings, there's a flurry of activity and new collaborations and new ideas, and I think you only really get that when you’re there in person and really in the moment.
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
April 2nd 2025Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Read More